Metazym is being trialed in Patients with late infantile Metachromatic Leukodystrophy[1]. The drug produced by Shire costs in the vicinity of US$90,000 per month [2]. A company spokesman notes that the drug will not be on the market until at least 2012


  • Currently 0.00/5

Rating: 0.0/5 (0 votes cast) login to rate

Add to Favorite Print This Page Publish on Twitter
Bookmark and Share
close about Number of comments per page:
Time format: relative absolute
You need JavaScript enabled for viewing comments